Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
We also use InBody body composition scans throughout the program to track lean mass separately from fat mass so both you and your provider know whether the weight you're losing is fat, not muscle
Phase 3 trials are ongoing with projected approval timelines between late 2026 and early 2027
Jurca CM, Kozma K, Petchesi CD, Zaha DC, Magyar I, Munteanu M, et al
Many patients can transition from semaglutide to tirzepatide under medical supervision
US$ 21.73
US$ 20.29
US$ 21.97
